Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 92 of 92 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/07/22
End: 11/18/24
Due: 11/18/25
Phase: N/A
Priority: Normal
Start: 01/16/13
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/30/06
End: 01/31/09
Due: 01/31/10
Phase: N/A
Priority: Normal
Start: 08/31/97
End: 08/31/05
Due: 08/31/06
Phase: N/A
Priority: Normal
Start: 04/09/99
End: 11/29/17
Due: 11/29/18
Phase: N/A
Priority: Normal
Start: 08/14/09
End: 02/07/26
Due: 02/07/27
Phase: N/A
Priority: Normal
Start: 10/30/06
End: 10/04/17
Due: 10/04/18
Phase: N/A
Priority: Normal
Start: 11/16/12
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 08/31/02
End: 06/30/06
Due: 06/30/07
Phase: N/A
Priority: Normal
Start: 09/01/23
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 04/18/16
End: 12/31/46
Due: 12/31/47
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 12/31/03
Due: 12/31/04
Phase: N/A
Priority: Normal
Start: 09/30/01
End: 10/31/04
Due: 10/31/05
Phase: N/A
Priority: Normal
Start: 05/18/21
End: 09/22/26
Due: 09/22/27
Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia
Phase: N/A
Priority: Normal
Start: 10/12/22
End: 01/09/26
Due: 01/09/27
Phase: N/A
Priority: Normal
Start: 10/05/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/21/04
End: 06/29/12
Due: 06/29/13